Ray Dalio’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5M | Buy |
227,746
+104,090
| +84% | +$5.72M | 0.05% | 231 |
|
|
2025
Q1 | $8.74M | Sell |
123,656
-178,824
| -59% | -$12.6M | 0.04% | 281 |
|
|
2024
Q4 | $19.9M | Buy |
302,480
+160,166
| +113% | +$10.5M | 0.09% | 168 |
|
|
2024
Q3 | $10M | Buy |
142,314
+107,330
| +307% | +$7.54M | 0.06% | 262 |
|
|
2024
Q2 | $2.88M | Buy |
34,984
+31,618
| +939% | +$2.6M | 0.02% | 465 |
|
|
2024
Q1 | $294K | Sell |
3,366
-187,604
| -98% | -$16.4M | ﹤0.01% | 657 |
|
|
2023
Q4 | $18.4M | Buy |
190,970
+29,576
| +18% | +$2.85M | 0.1% | 152 |
|
|
2023
Q3 | $14.3M | Buy |
161,394
+11,418
| +8% | +$1.01M | 0.09% | 177 |
|
|
2023
Q2 | $13M | Buy |
149,976
+25,932
| +21% | +$2.25M | 0.08% | 170 |
|
|
2023
Q1 | $12.1M | Buy |
124,044
+17,665
| +17% | +$1.72M | 0.07% | 184 |
|
|
2022
Q4 | $11M | Sell |
106,379
-1,165
| -1% | -$121K | 0.06% | 239 |
|
|
2022
Q3 | $9.12M | Buy |
107,544
+67,829
| +171% | +$5.75M | 0.05% | 266 |
|
|
2022
Q2 | $3.29M | Buy |
39,715
+20,065
| +102% | +$1.66M | 0.01% | 592 |
|
|
2022
Q1 | $1.52M | Buy |
19,650
+5,667
| +41% | +$437K | 0.01% | 736 |
|
|
2021
Q4 | $1.24M | Sell |
13,983
-27
| -0.2% | -$2.39K | 0.01% | 536 |
|
|
2021
Q3 | $1.08M | Sell |
14,010
-9,171
| -40% | -$709K | 0.01% | 503 |
|
|
2021
Q2 | $1.93M | Buy |
23,181
+9,743
| +73% | +$813K | 0.01% | 494 |
|
|
2021
Q1 | $1.02M | Buy |
+13,438
| New | +$1.02M | 0.01% | 313 |
|
|
2016
Q4 | – | Sell |
-8,926
| Closed | -$826K | – | 284 |
|
|
2016
Q3 | $826K | Buy |
+8,926
| New | +$826K | 0.01% | 234 |
|
|
2014
Q2 | – | Sell |
-48,400
| Closed | -$3.3M | – | 319 |
|
|
2014
Q1 | $3.3M | Buy |
+48,400
| New | +$3.3M | 0.03% | 148 |
|